Short Interest in Bio-Path Holdings, Inc. (NASDAQ:BPTH) Declines By 59.3%

Bio-Path Holdings, Inc. (NASDAQ:BPTH) saw a large decline in short interest in April. As of April 15th, there was short interest totalling 27,400 shares, a decline of 59.3% from the March 31st total of 67,400 shares. Approximately 3.6% of the shares of the stock are sold short. Based on an average daily trading volume, of 1,380,000 shares, the days-to-cover ratio is presently 0.0 days.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on BPTH shares. StockNews.com started coverage on shares of Bio-Path in a research report on Wednesday. They issued a “sell” rating for the company. Roth Mkm reiterated a “buy” rating and set a $40.00 price objective on shares of Bio-Path in a research report on Thursday, April 18th.

Bio-Path Price Performance

BPTH stock traded up $0.05 during trading on Friday, reaching $2.68. 117,120 shares of the company were exchanged, compared to its average volume of 1,109,229. The company has a 50-day moving average of $4.77 and a two-hundred day moving average of $8.35. The company has a market capitalization of $1.82 million, a price-to-earnings ratio of -0.07 and a beta of 0.35. Bio-Path has a twelve month low of $2.35 and a twelve month high of $44.80.

Bio-Path (NASDAQ:BPTH) last posted its earnings results on Friday, March 8th. The company reported ($5.40) earnings per share for the quarter, hitting analysts’ consensus estimates of ($5.40). During the same quarter in the prior year, the business earned ($10.60) EPS. On average, analysts forecast that Bio-Path will post -18.71 EPS for the current year.

About Bio-Path

Bio-Path Holdings, Inc operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction.